Rigshospitalet, Denmark: Neoplasm Metastasis trials
The registry lists 13 Neoplasm Metastasis studies with Rigshospitalet, Denmark as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 3 1No phase 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).RecruitingNCT05354596Not applicable
- Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort StudyNot yet recruitingNCT04788927
- Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?Active, not recruitingNCT06592716
- Re-TREAT: Re-irradiation for Relapsed Brain MetastasesStatus unknownNCT05126875Not applicable
- Postoperative Exercise Training in Patients With Colorectal Liver Metastases Undergoing Surgery (ELMA)Active, not recruitingNCT04751773Not applicable
- Mediastinal Lymph Node Dissection in Conjunction With Pulmonary Metastasectomy From Colorectal CancerStatus unknownNCT03113318Not applicable
- Is the Volume of the Caudate Nuclei Associated With Area of Secondary Hyperalgesia?CompletedNCT02567318Not applicable
- Delineating Areas of Secondary Hyperalgesia: Influence of the Assessment MethodCompletedNCT02286037
- Stereotactic Radiosurgery in Metastatic Spinal Cord CompressionTerminatedNCT02167633Not applicable
- Surgical Spinal Decompression of Metastatic Spinal Cord Compression, Minimal Access Versus Open SurgeryCompletedNCT01865942Not applicable
- Preoperative Embolization in Surgical Treatment of Spinal Metastases.CompletedNCT01365715Not applicable
- Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PETStatus unknownNCT01224873
- Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent MiscarriageCompletedNCT00722475Phase 3